Physician profile
Nathan A Roesner
NPI 1598886483
$2,111.85
in general payments reported to CMS, 2019-2025
11 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $212 · 2021: $171 · 2022: $85.91 · 2023: $642 · 2024: $321 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,288 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.24 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $696.09 | 2019-2025 | Trumatch, Na, Matrixmandible |
| Abbvie INC. | $293.71 | 2023-2025 | Botox, Alloderm, Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $245.00 | 2019-2022 | |
| Tela Bio, INC. | $228.59 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $193.25 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $174.66 | 2023 | |
| Stryker Corporation | $121.02 | 2020-2025 | Na |
| Integra Lifesciences Corporation | $59.34 | 2023-2025 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Revance Therapeutics, INC. | $54.68 | 2024 | Daxxify |
| Innovation Technologies INC | $23.67 | 2022 | |
| Coopersurgical, INC. | $21.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Roesner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.